Kamran Shamaei - Monogram Orthopaedics Chief Officer
| MGRM Stock | 3.12 0.24 7.14% |
Executive
Kamran Shamaei is Chief Officer of Monogram Orthopaedics Common
| Age | 41 |
| Address | 3913 Todd Lane, Austin, TX, United States, 78744 |
| Phone | 512 399 2656 |
| Web | https://www.monogramtechnologies.com |
Monogram Orthopaedics Management Efficiency
The company has return on total asset (ROA) of (0.5568) % which means that it has lost $0.5568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0074) %, meaning that it created substantial loss on money invested by shareholders. Monogram Orthopaedics' management efficiency ratios could be used to measure how well Monogram Orthopaedics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 21st of March 2025, Return On Tangible Assets is likely to drop to -0.98. In addition to that, Return On Capital Employed is likely to grow to -0.9. At this time, Monogram Orthopaedics' Total Current Assets are very stable compared to the past year. As of the 21st of March 2025, Non Currrent Assets Other is likely to grow to about 850.5 K, while Non Current Assets Total are likely to drop about 1.4 M.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Julian Paul | MYT Netherlands Parent | N/A | |
| Bjorn Kastl | MYT Netherlands Parent | N/A | |
| Damien Harmon | Best Buy Co | 46 | |
| Jason Bonfig | Best Buy Co | 47 | |
| Daniel MacEachran | Braskem SA Class | N/A | |
| Brandon Ontjes | Chemours Co | N/A | |
| Edison Filho | Braskem SA Class | 52 | |
| Roberto Bischoff | Braskem SA Class | 68 | |
| Ron Charles | Chemours Co | 54 | |
| James Sun | Tradeweb Markets | N/A | |
| Yijun Wang | The Mosaic | 57 | |
| Joo Rittershaussen | Braskem SA Class | 61 | |
| Tiffany Hsu | MYT Netherlands Parent | N/A | |
| Luiz Nunes | Braskem SA Class | 61 | |
| Flvio Rossini | Braskem SA Class | N/A | |
| Kristin McCoy | NL Industries | 52 | |
| Brian Shay | Chemours Co | N/A | |
| Douglas JD | Tradeweb Markets | 55 | |
| Fernando Musa | Braskem SA Class | 53 | |
| Edison Terra | Braskem SA Class | 48 | |
| Walter III | The Mosaic | 61 | |
Management Performance
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.56 |
Monogram Orthopaedics Leadership Team
Elected by the shareholders, the Monogram Orthopaedics' board of directors comprises two types of representatives: Monogram Orthopaedics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Monogram. The board's role is to monitor Monogram Orthopaedics' management team and ensure that shareholders' interests are well served. Monogram Orthopaedics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Monogram Orthopaedics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Benjamin CFA, President Board | ||
| Chris Tyson, Executive America | ||
| Douglas Unis, Chief Founder | ||
| Kamran Shamaei, Chief Officer |
Monogram Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Monogram Orthopaedics a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.56 | ||||
| Current Valuation | 103.28 M | ||||
| Shares Outstanding | 35.29 M | ||||
| Shares Owned By Insiders | 34.09 % | ||||
| Shares Owned By Institutions | 4.20 % | ||||
| Number Of Shares Shorted | 113.2 K | ||||
| Price To Book | 8.18 X | ||||
| Price To Sales | 243.53 X | ||||
| Gross Profit | 365 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Monogram Orthopaedics Common. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Monogram Orthopaedics. If investors know Monogram will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Monogram Orthopaedics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Monogram Orthopaedics is measured differently than its book value, which is the value of Monogram that is recorded on the company's balance sheet. Investors also form their own opinion of Monogram Orthopaedics' value that differs from its market value or its book value, called intrinsic value, which is Monogram Orthopaedics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Monogram Orthopaedics' market value can be influenced by many factors that don't directly affect Monogram Orthopaedics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Monogram Orthopaedics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Monogram Orthopaedics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Monogram Orthopaedics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.